JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 9, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/46/43031    most recent
M107597200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, S.-H.
Right arrow Articles by Waxman, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, S.-H.
Right arrow Articles by Waxman, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print September 18, 2001
J. Biol. Chem, 10.1074/jbc.M107597200
Submitted on August 9, 2001
Revised on September 6, 2001
Accepted on September 17, 2001

Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta. Impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P450 gene expression

Soo-Hee Park and David J. Waxman

Department of Biology, Boston University, Boston, MA 02215

Corresponding Author: djw{at}bu.edu

STAT5b is repeatedly activated in rodent liver by the male pattern of intermittent plasma growth hormone (GH) stimulation and is required to maintain the GH pulse-regulated, male-specific pattern of liver gene expression. We presently investigate the interactions between STAT5b and hepatocyte-enriched nuclear factors (HNFs) that contribute to regulation of GH pulse-inducible, male-specific liver cytochrome P450 (CYP) genes. STAT5 binding sites were identified in the 5’-flank of the adult male-expressed genes CYP2A2 (nucleotides –2255 to -2247), CYP4A2 (-1872 to -1864) and CYP2C11 (-1150 to -1142). STAT5-DNA complexes were formed by each CYP sequence with nuclear extract from GH pulse-activated male, but not female, rat liver. The CYP2C11 STAT5 site, which is flanked by HNF3 consensus sequences, conferred STAT5b-inducible reporter gene activity in GH-treated HepG2 cells. trans-Activation of the intact CYP2C11 promoter (1.8 kb 5’-flank) was strongly induced by the liver nuclear factors HNF1a and HNF3b, but unexpectedly, was inhibited by GH-activated STAT5b. This STAT5b inhibitory effect could be reversed by HNF1a, and reflects a functional antagonism between STAT5b and HNF3b, as evidenced by the inhibition of HNF3b DNA-binding and transcriptional activity by STAT5b. HNF3b, in turn, inhibited STAT5b by a novel mechanism that leads to suppression of GH-inducible STAT5b tyrosine phosphorylation, DNA-binding and transcriptional activity. The potential for GH-activated STAT5b to stimulate male-specific liver CYP expression can thus be modulated by HNF3b, highlighting the complex interrelationship between STAT5b and liver transcription factors controlling expression of GH-regulated CYP genes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
R. M. Sawaya and D. S. Riddick
Cytochrome P450 2C11 5'-Flanking Region and Promoter Mediate in Vivo Suppression by 3-Methylcholanthrene
Drug Metab. Dispos., September 1, 2008; 36(9): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Wauthier and D. J. Waxman
Sex-Specific Early Growth Hormone Response Genes in Rat Liver
Mol. Endocrinol., August 1, 2008; 22(8): 1962 - 1974.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Lofgren, R. M. Baldwin, M. Hiratsuka, A. Lindqvist, A. Carlberg, S. C. Sim, M. Schulke, M. Snait, A. Edenro, R. Fransson-Steen, et al.
Generation of Mice Transgenic for Human CYP2C18 and CYP2C19: Characterization of the Sexually Dimorphic Gene and Enzyme Expression
Drug Metab. Dispos., May 1, 2008; 36(5): 955 - 962.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. N. Dhir, C. Thangavel, and B. H. Shapiro
Attenuated Expression of Episodic Growth Hormone-Induced CYP2C11 in Female Rats Associated with Suboptimal Activation of the Jak2/Stat5B and Other Modulating Signaling Pathways
Drug Metab. Dispos., November 1, 2007; 35(11): 2102 - 2110.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. V. Laz, M. G. Holloway, C.-S. Chen, and D. J. Waxman
Characterization of Three Growth Hormone-Responsive Transcription Factors Preferentially Expressed in Adult Female Liver
Endocrinology, July 1, 2007; 148(7): 3327 - 3337.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Jiang, Y. Wang, M. Wu, Z. Gu, S. J. Frank, and R. Torres-Diaz
Growth Hormone Stimulates Hepatic Expression of Bovine Growth Hormone Receptor Messenger Ribonucleic Acid through Signal Transducer and Activator of Transcription 5 Activation of a Major Growth Hormone Receptor Gene Promoter
Endocrinology, July 1, 2007; 148(7): 3307 - 3315.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Thangavel and B. H. Shapiro
A Molecular Basis for the Sexually Dimorphic Response to Growth Hormone
Endocrinology, June 1, 2007; 148(6): 2894 - 2903.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. J. Waxman and C. O'Connor
Growth Hormone Regulation of Sex-Dependent Liver Gene Expression
Mol. Endocrinol., November 1, 2006; 20(11): 2613 - 2629.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Lee, J. R. Hutson, V. K.-F. Tzau, and D. S. Riddick
Regulation of Constitutive Mouse Hepatic Cytochromes P450 and Growth Hormone Signaling Components by 3-Methylcholanthrene
Drug Metab. Dispos., September 1, 2006; 34(9): 1530 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. G. Holloway, E. V. Laz, and D. J. Waxman
Codependence of Growth Hormone-Responsive, Sexually Dimorphic Hepatic Gene Expression on Signal Transducer and Activator of Transcription 5b and Hepatic Nuclear Factor 4{alpha}
Mol. Endocrinol., March 1, 2006; 20(3): 647 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Richardson and E. T. Morgan
Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 703 - 709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. L. Shumate, G. Yumet, T. A. Ahmed, and R. N. Cooney
Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes
Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G227 - G239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Wiwi and D. J. Waxman
Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2
J. Biol. Chem., February 4, 2005; 280(5): 3259 - 3268.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Eleswarapu and H Jiang
Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver
J. Endocrinol., January 1, 2005; 184(1): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Wiwi, M. Gupte, and D. J. Waxman
Sexually Dimorphic P450 Gene Expression in Liver-Specific Hepatocyte Nuclear Factor 4{alpha}-Deficient Mice
Mol. Endocrinol., August 1, 2004; 18(8): 1975 - 1987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Scassa, A. S. Guberman, J. M. Ceruti, and E. T. Canepa
Hepatic Nuclear Factor 3 and Nuclear Factor 1 Regulate 5-Aminolevulinate Synthase Gene Expression and Are Involved in Insulin Repression
J. Biol. Chem., July 2, 2004; 279(27): 28082 - 28092.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. S. Riddick, C. Lee, A. Bhathena, Y. E. Timsit, P.-Y. Cheng, E. T. Morgan, R. A. Prough, S. L. Ripp, K. K. M. Miller, A. Jahan, et al.
TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
Drug Metab. Dispos., April 1, 2004; 32(4): 367 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P.-Y. Cheng, M. Wang, and E. T. Morgan
Rapid Transcriptional Suppression of Rat Cytochrome P450 Genes by Endotoxin Treatment and Its Inhibition by Curcumin
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. J. Waxman and J. L. Celenza
Sexual dimorphism of hepatic gene expression: novel biological role of KRAB zinc finger repressors revealed
Genes & Dev., November 1, 2003; 17(21): 2607 - 2613.
[Full Text] [PDF]


Home page
EndocrinologyHome page
T. M. Badger, M. J. J. Ronis, S. J. Frank, Y. Chen, and L. He
Effects of Chronic Ethanol on Hepatic and Renal CYP2C11 in the Male Rat: Interactions with the Janus-Kinase 2-Signal Transducer and Activators of Transcription Proteins 5b Pathway
Endocrinology, September 1, 2003; 144(9): 3969 - 3976.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Shipley and D. J. Waxman
Down-Regulation of STAT5b Transcriptional Activity by Ligand-Activated Peroxisome Proliferator-Activated Receptor (PPAR) {alpha} and PPAR{gamma}
Mol. Pharmacol., August 1, 2003; 64(2): 355 - 364.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. L. Uprichard, S. F. Wieland, A. Althage, and F. V. Chisari
Transcriptional and posttranscriptional control of hepatitis B virus gene expression
PNAS, February 4, 2003; 100(3): 1310 - 1315.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. M. Rausa, Y. Tan, and R. H. Costa
Association between Hepatocyte Nuclear Factor 6 (HNF-6) and FoxA2 DNA Binding Domains Stimulates FoxA2 Transcriptional Activity but Inhibits HNF-6 DNA Binding
Mol. Cell. Biol., January 15, 2003; 23(2): 437 - 449.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Bhathena, C. Lee, and D. S. Riddick
Suppression of Cytochrome P450 2C11 by Aromatic Hydrocarbons: Mechanistic Insights from Studies of the 5'-Flanking Region of the CYP2C11 Gene
Drug Metab. Dispos., December 1, 2002; 30(12): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. E. Timsit and D. S. Riddick
Stimulation of Hepatic Signal Transducer and Activator of Transcription 5b by GH Is Not Altered by 3-Methylcholanthrene
Endocrinology, September 1, 2002; 143(9): 3284 - 3294.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.